Diabetes in early pregnancy: Getting to the heart of the matter

Diabetes

Volumn 62, Issue 1, 2013, Pages 27-28

  Gilbert, Jeffrey S ^a   Banek, Christopher T ^a   Babcock, Sara A ^b   Dreyer, Hans C ^a  

^a UNIVERSITY OF OREGON   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYCLIN D1; GLUCOSE; GLUCOSE TRANSPORTER 1; REACTIVE OXYGEN METABOLITE;

CELL CYCLE PROGRESSION; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; FETUS DISTRESS; GLUCOSE INTOLERANCE; HEART DEVELOPMENT; HYPERGLYCEMIA; NONHUMAN; NOTE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; HYPERGLYCEMIA; PREGNANCY;

EID: 84872017559     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-1117     Document Type: Note

References (14)

1. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998;351:173-177 (Pubitemid 28037007)
2. Nehiri T, Duong Van Huyen J-P, Viltard M, et al. Exposure to maternal diabetes induces salt-sensitive hypertension and impairs renal function in adult rat offspring. Diabetes 2008;57:2167-2175
3. Gilbert JS, Nijland MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol 2008;295:R1941-R1952
4. Amri K, Freund N, Vilar J, Merlet-Bénichou C, Lelièvre- Pégorier M. Adverse effects of hyperglycemia on kidney development in rats: in vivo and in vitro studies. Diabetes 1999;48:2240-2245 (Pubitemid 29521856)
5. Wentzel P, Gäreskog M, Eriksson UJ. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005;54:546-553
6. Chang S-Y, Chen Y-W, Zhao X-P, et al. Catalase prevents maternal diabetes-induced perinatal programming via the Nrf2-HO-1 defense system. Diabetes 2012;61:2565-2574
7. Roest PA, Molin DG, Schalkwijk CG, et al. Specific local cardiovascular changes of Nepsilon-(carboxymethyl)lysine, vascular endothelial growth factor, and Smad2 in the developing embryos coincide with maternal diabetes-induced congenital heart defects. Diabetes 2009;58:1222-1228
8. Eriksson UJ. Congenital anomalies in diabetic pregnancy. Semin Fetal Neonatal Med 2009;14:85-93
9. Scott-Dreschel DE, Rugonyi S, Marks DL, Thornburg KL, Hinds MT. Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21. Diabetes 2013;62:234-242
10. Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes 2012;61:549-559
11. Lin KH, Guh JY, Mo JF, Chiou SJ, Hwang CC, Chuang LY. Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells. Arch Biochem Biophys 2008;477:27-32
12. Cagnone GL, Dufort I, Vigneault C, Sirard MA. Differential gene expression profile in bovine blastocysts resulting from hyperglycemia exposure during early cleavage stages. Biol Reprod 2012;86:50
13. Brizzi MF, Dentelli P, Gambino R, et al. STAT5 activation induced by diabetic LDL depends on LDL glycation and occurs via src kinase activity. Diabetes 2002;51:3311-3317 (Pubitemid 35246979)
14. Oliver EA, Buhimschi CS, Dulay AT, et al. Activation of the receptor for advanced glycation end products system in women with severe pre-eclampsia. J Clin Endocrinol Metab 2011;96:689-698